- This event has passed.
November Scientific Meeting 11/13/21
November 13 @ 4:00 pm - 6:00 pmFree – $25.00
Western New England Psychoanalytic Society
Saturday, November 13th 4pm–6pm
WNEPS members, WNEIP candidates and all students/trainees attend free
Non-members: $25 professional registration fee (includes CME/CE certificate with completed evaluation)
This meeting is virtual. To successfully attend, please read the following instructions:
Register at the link below.
The day before the meeting an email containing the ZOOM link will be sent from [email protected] to all registrants.
The day of the meeting click the Zoom link in the email to join the meeting.
See below for important CME/CE certificate details.
Psychedelic Therapy and Neuroscience
Presenter: Robin Carhart-Harris, PhD
Discussant: Robert Ostroff, MD
This talk takes a multi-level approach to the question of how psychedelics work in the brain. Key themes include: the pharmacology of classic serotonergic psychedelics, what this tells us about the current, developmental and evolutionary function of serotonin 2A receptor signaling (inc. how the ego may have developed), the acute brain effects of psychedelics (e.g., in relation to ego-dissolution) as determined by functional brain imaging, current evidence for psychedelic therapy, the ‘REBUS’ model of the action of psychedelics, and how this maps on to the phenomenology of the acute psychedelic experience and therapeutic outcomes. The talk will end with a focus on a recent double-blind RCT comparing psilocybin therapy with an established antidepressant drug in the treatment of depression.
- Explain pharmacology of psychedelics and evidence for positive clinical outcomes in psychedelic treatment.
- Explain system level effects of psychedelics on ego dissolution, aspects of free-association and therapeutic change.
About Robin Carhart-Harris, PhD
Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol, focused on the serotonin system, an MA in Psychoanalysis from Brunel University, 2005, and a BSc in Psychology and Computing from Bournemouth University. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, a clinical trial of psilocybin for treatment-resistant depression, a double-blind randomized controlled trial comparing psilocybin with the SSRI, escitalopram, for depression, published in the New England Journal of Medicine, and a multimodal imaging study in first time users of psilocybin. Robin has published over 115 scientific papers. He founded the Centre for Psychedelic Research at Imperial College London in April 2019. In 2021, he was listed in TIME magazine’s ‘100 Next’, a list of 100 rising stars shaping the future. From July 1st, 2021, he moved to University of California, San Francisco, becoming the Ralph Metzner Distinguished Professor in Neurology and Psychiatry. At UCSF, Robin will Direct the new Psychedelics Division within the translational neuroscience Centre, Neuroscape.
In order to receive CME or CE credits participants must attend the full program and complete an evaluation. A link to the evaluation will be sent via an email reminder within a few days of the program.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American Psychoanalytic Association and Western New England Psychoanalytic Society. The American Psychoanalytic Association is accredited by the ACCME to provide continuing medical education for physicians.”
The American Psychoanalytic Association designates this Live Activity for a maximum of two AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
IMPORTANT DISCLOSURE INFORMATION FOR ALL LEARNERS: None of the planners and presenters for this educational activity have relevant financial relationship(s)* to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
*Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.
This program is being reviewed for Continuing Education Credit hours by the NASW, CT to meet the continuing education criteria for CT Social Work Licensure renewal.
A Certificate of Attendance for WNE Programs can be used to fulfill CE requirements for CT Psychologists.